Edgewise Therapeutics Inc (NASDAQ:EWTX) shares, rose in value, with the stock price up by 6.73% to the previous day’s close as strong demand from buyers drove the stock to $23.76.
Actively observing the price movement in the recent trading, the stock is buoying the session at $22.26, falling within a range of $21.5769 and $25.36. The value of beta (5-year monthly) is 0.227. Referring to stock’s 52-week performance, its high was $38.12, and the low was $14.90. On the whole, EWTX has fluctuated by -7.09% over the past month.
With the market capitalization of Edgewise Therapeutics Inc currently standing at about $2.26 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-02.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EWTX’s technical picture suggests that short-term indicators denote the stock is a 75% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of EWTX currently trading nearly -6.33% and -10.01% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.14, while the 7-day volatility ratio is showing 6.79% which for the 30-day chart, stands at 8.30%. Furthermore, Edgewise Therapeutics Inc (EWTX)’s beta value is 0.30, and its average true range (ATR) is 2.07.
A comparison of Edgewise Therapeutics Inc (EWTX) with its peers suggests the former has fared considerably weaker in the market. EWTX showed an intraday change of 6.73% in today’s session so far, and over the past year, it grew by 48.49%%.
Data on historical trading for Edgewise Therapeutics Inc (NASDAQ:EWTX) indicates that the trading volumes over the past 10 days have averaged 1.56 and over the past 3 months, they’ve averaged 1.14 million. According to company’s latest data on outstanding shares, there are 94.84 million shares outstanding.
Nearly 29.38% of Edgewise Therapeutics Inc’s shares belong to company insiders and institutional investors own 78.78% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.09 million shares as on 2025-03-14, resulting in a short ratio of 6.69. According to the data, the short interest in Edgewise Therapeutics Inc (EWTX) stood at 1392.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 8.06 million. The stock has fallen by -11.02% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EWTX stock heading into the next quarter.
